CONFERENCE--IMPACT OF NEW GENETIC TECH ON LAW, MEDICINE

会议——新基因技术对法律、医学的影响

• 批准号: 6191223
• 负责人: David C. Page
• 金额: $ 4.65万
• 依托单位: WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-03-01 至 2001-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6191223
• 关键词: biotechnology; ethics; genetic screening; genetic techniques; health care policy; health related legal; health science research; human rights; meeting /conference /symposium; religion; sociology /anthropology; travel

DESCRIPTION: (Applicant's Abstract) The proposed conference, Genetics and Society: Impact of New Technologies on Law, Medicine, and Policy, will bring together more than 800 physicians, lawyers, ethicists, scientists, clergy, students, consumers, and consumer advocates to explore the opportunities and challenges emerging from today's research. Headlines from across the country illustrate the growing public interest in the genetics revolution. Whether the topic is genetically engineered food, mandatory DNA testing, advances in molecular medicine, or genetic privacy, people want to know when and how they will be affected. Yet community leaders such as, physicians, lawyers, legislators, clergy, and teachers, often lack the information required to provide satisfactory answers. The conference, organized by the Whitehead Institute for Biomedical Research, in association with the American Society of Law, Medicine and Ethics (ASLME) will take place on May 10, 11, and 12, 2000. Confirmed speakers and panelists include: Dr. Harold Varmus, Director of NIH; Justice Stephen Breyer of the U.S. Supreme Court; Dr. Steven Hyman, Director of the National Institute of Mental Health; Dr. Marcia Angell, Editor-in-Chief of the New England Journal of Medicine; Dr. Eric S. Lander, Director of the Whitehead/MIT Center for Genome Research; and Dr. Arthur L. Caplan, Director of the Center for Bioethics at the University of Pennsylvania. The Whitehead Institute and ASLME plan to offer the conference for three reasons: (1) the overwhelming response to a previous interdisciplinary symposium on the Human Genome Project (1998), which attracted more than double the number of expected attendees; (2) the rapid changes in technology over the past two years; and (3) the dramatic rise in public interest and concern about a broad range of topics in human genetics and agriculture. Participants will leave the conference with a clear perspective on how current advances in biology will affect their own fields, extensive background materials, continuing education credits (in medicine and law), and new insights into the impact of the genetics revolution on society as a whole. The conference organizers will disseminate the results of the conference through a specially prepared CD-ROM; through a special issue of ASLME's Journal of Law, Medicine & Ethics; and through articles submitted to leading medical and scientific journals.

描述：(申请人摘要)拟召开的会议、遗传学和 社会：新技术对法律、医学和政策的影响 800多名医生、律师、伦理学家、科学家、神职人员， 学生、消费者和消费者权益倡导者探索机会和 从今天的研究中出现的挑战。全国各地的头条新闻 说明公众对基因革命的兴趣与日俱增。无论是 主题是转基因食品，强制DNA检测，在 分子医学，或遗传隐私，人们想知道他们何时以及如何 都会受到影响。然而，社区领袖，如医生，律师， 立法者、神职人员和教师通常缺乏所需的信息 提供令人满意的答案。由怀特黑德组织的这次会议 生物医学研究所，与美国医学学会 法律、医学和道德(ASLME)将于2000年5月10日、11日和12日举行。 已确认的发言者和小组成员包括：美国国立卫生研究院院长哈罗德·瓦默斯博士； 美国最高法院大法官斯蒂芬·布雷耶；史蒂文·海曼博士 国家心理健康研究所；Marcia Angell博士， 《新英格兰医学杂志》；埃里克·S·兰德博士， 怀特黑德/麻省理工学院基因组研究中心；亚瑟·L·卡普兰博士， 宾夕法尼亚大学生物伦理学中心。《白头翁》 协会和ASLME计划举办这次会议有三个原因：(1) 对之前关于人类的跨学科研讨会的压倒性反响 基因组计划(1998)，吸引了预期数量的两倍多 与会者；(2)过去两年技术的快速变化；(3) 公众对广泛话题的兴趣和关注的急剧上升 在人类遗传学和农业方面。与会者将带着以下信息离开会议 一个关于当前生物学进步将如何影响它们自身的清晰视角 领域、广泛的背景材料、继续教育学分(in 医学和法律)，以及对遗传学革命影响的新见解 对整个社会的影响。会议组织者将公布结果 通过一张特别准备的光盘；通过一期特刊 发表在ASLME《法律、医学与伦理杂志》上； 领先的医学和科学期刊。